인쇄하기
취소

Dong-A to enter "sibutramine" anti-obesity drug markets

Published: 2007-09-04 06:59:00
Updated: 2007-09-04 06:59:00
Dong-A is going to launch Shranker capsule (sibutramine), an anti-obesity drug, into the markets. Shranker means a "shrink" in German, implying the reduction of a wait size and body fats.

Shranker was formulated with sibutramine without salt, showing its safety and bio-equivalency by clinical studies, Dong-A said.

Clinical studies on sibutramine preparations revealed that more than 77% of...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.